Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 310,111 $ 116,209,889 $ (118,789,000) $ (2,269,000)
Beginning balance, shares at Dec. 31, 2019 310,111,536      
Common stock issued on exercise of warrants and options $ 1,215 59,785 61,000
Common stock issued on exercise of warrants and options, shares 1,215,000      
Common stock issued on conversion of notes payable $ 8,096 366,904 375,000
Common stock issued on conversion of notes payable, shares 8,094,707      
Warrants issued with convertible notes 212,000 212,000
Fair value of options and warrants issued as compensation 213,000 213,000
Net loss (1,607,000) (1,607,000)
Ending balance, value at Jun. 30, 2020 $ 319,422 117,061,578 (120,396,000) (3,015,000)
Ending balance, shares at Jun. 30, 2020 319,421,243      
Beginning balance, value at Mar. 31, 2020 $ 314,972 116,641,028 (119,555,000) (2,599,000)
Beginning balance, shares at Mar. 31, 2020 314,972,209      
Common stock issued on exercise of warrants and options
Common stock issued on conversion of notes payable $ 4,450 151,550 156,000
Common stock issued on conversion of notes payable, shares 4,449,034      
Warrants issued with convertible notes 177,000 177,000
Fair value of options and warrants issued as compensation 92,000 92,000
Common stock issued for services
Net loss (841,000) (841,000)
Ending balance, value at Jun. 30, 2020 $ 319,422 117,061,578 (120,396,000) (3,015,000)
Ending balance, shares at Jun. 30, 2020 319,421,243      
Beginning balance, value at Dec. 31, 2020 $ 323,182 117,373,818 (121,204,000) (3,507,000)
Beginning balance, shares at Dec. 31, 2020 323,181,243      
Adjustment for adoption of ASU 2020-06 (60,000) 30,000 (30,000)
Common stock issued on conversion of notes payable $ 6,396 126,604 133,000
Common stock issued on conversion of notes payable, shares 6,395,988      
Warrants issued with convertible notes 99,000 99,000
Fair value of options and warrants issued as compensation 18,000 18,000
Common stock issued in private sale of securities $ 8,533 119,467 128,000
Fair value of common stock issued in private sale of securities, shares 8,533,333      
Net loss (645,000) (645,000)
Ending balance, value at Jun. 30, 2021 $ 338,111 117,676,889 (121,819,000) (3,804,000)
Ending balance, shares at Jun. 30, 2021 338,110,564      
Beginning balance, value at Mar. 31, 2021 $ 328,382 117,440,618 (121,545,000) (3,776,000)
Beginning balance, shares at Mar. 31, 2021 328,381,243      
Common stock issued on exercise of warrants and options
Common stock issued on conversion of notes payable $ 4,196 84,804 89,000
Common stock issued on conversion of notes payable, shares 4,195,988      
Warrants issued with convertible notes 69,000 69,000
Fair value of options and warrants issued as compensation 5,000 5,000
Common stock issued in private sale of securities $ 5,533 77,467 83,000
Fair value of common stock issued in private sale of securities, shares 5,533,333      
Net loss (274,000) (274,000)
Ending balance, value at Jun. 30, 2021 $ 338,111 $ 117,676,889 $ (121,819,000) $ (3,804,000)
Ending balance, shares at Jun. 30, 2021 338,110,564